Carl L. Gordon's most recent trade in ADARx Pharmaceuticals Inc. was a trade of 10,690,530 shares done . Disclosure was reported to the exchange on Sept. 28, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ADARx Pharmaceuticals Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 28 Sep 2026 | 10,690,530 | 10,690,530 | - | - | - | ||
| ADARx Pharmaceuticals Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 28 Sep 2026 | 7,127,019 | 7,127,019 | - | - | - | ||
| ADARx Pharmaceuticals Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 28 Sep 2026 | 2,000,962 | 12,691,492 | - | - | - | ||
| ADARx Pharmaceuticals Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 28 Sep 2026 | 1,333,975 | 8,460,994 | - | - | - | ||
| ADARx Pharmaceuticals Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 28 Sep 2026 | 769,601 | 13,461,093 | - | - | - | ||
| ADARx Pharmaceuticals Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 28 Sep 2026 | 588,235 | 588,235 | - | 17 | 9,999,995 | - |
| ADARx Pharmaceuticals Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 28 Sep 2026 | 564,187 | 14,025,280 | - | - | - | ||
| ADARx Pharmaceuticals Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 28 Sep 2026 | 513,067 | 8,974,061 | - | - | - | ||
| ADARx Pharmaceuticals Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 28 Sep 2026 | 300,249 | 14,325,529 | - | 17 | 5,104,233 | - |
| ADARx Pharmaceuticals Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 28 Sep 2026 | 256,448 | 9,230,509 | - | - | - | ||
| ADARx Pharmaceuticals Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 28 Sep 2026 | 61,516 | 9,292,025 | - | 17 | 1,045,772 | - |
| Electra Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 21 Sep 2026 | 2,002,310 | 2,002,310 | - | - | - | ||
| Electra Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 21 Sep 2026 | 1,703,314 | 4,793,558 | - | - | - | ||
| Electra Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 21 Sep 2026 | 1,087,934 | 3,090,244 | - | - | - | ||
| Electra Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 21 Sep 2026 | 1,000,000 | 1,758,279 | - | 15 | 15,000,000 | - |
| Electra Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 21 Sep 2026 | 758,279 | 758,279 | - | - | - | ||
| Electra Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 21 Sep 2026 | 333,333 | 5,126,891 | - | 15 | 4,999,995 | - |
| BlossomHill Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director | 10 Aug 2026 | 1,049,283 | 2,089,279 | - | - | Common Stock | ||
| BlossomHill Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director | 10 Aug 2026 | 1,049,283 | 0 | - | - | Series B Preferred Stock | ||
| BlossomHill Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director | 10 Aug 2026 | 1,039,996 | 1,039,996 | - | - | Common Stock | ||
| BlossomHill Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director | 10 Aug 2026 | 1,039,996 | 0 | - | - | Series A Preferred Stock | ||
| BlossomHill Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 10 Aug 2026 | 625,000 | 2,714,279 | - | 16 | 10,000,000 | Common Stock |
| BlossomHill Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director | 06 Aug 2026 | 23,904 | 23,904 | - | - | Director Stock Option (Right to Buy) | ||
| Scribe Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director | 23 Jul 2026 | 2,065,672 | 0 | - | - | Series B Preferred Stock | ||
| Scribe Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 23 Jul 2026 | 1,000,000 | 1,348,825 | - | 15 | 15,000,000 | Common Stock |
| Scribe Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director | 23 Jul 2026 | 348,825 | 348,825 | - | - | Common Stock | ||
| Scribe Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director | 23 Jul 2026 | 14,725 | 14,725 | - | - | Stock Option (Right to Buy) | ||
| Compass Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director | 02 Jan 2026 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | ||
| Keros Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director | Sale or transfer of securities back to the company at price $ 17.75 per share. | 21 Nov 2025 | 140,057 | 759,155 | - | 17.8 | 2,486,012 | Common Stock |
| Keros Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director | Sale or transfer of securities back to the company at price $ 17.75 per share. | 21 Nov 2025 | 74,465 | 45,057 | - | 17.8 | 1,321,754 | Common Stock |
| Keros Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director | 04 Jun 2025 | 10,500 | 10,500 | - | - | Stock Option (right to buy) | ||
| Keros Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 5,250 | 5,250 | - | 0 | Common Stock | |
| Compass Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.59 per share. | 09 Apr 2025 | 3,571,428 | 0 | - | 1.6 | 5,678,571 | Common Stock |
| MBX Biosciences Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 10.84 per share. | 14 Feb 2025 | 94,100 | 747,887 | - | 10.8 | 1,020,044 | Common Stock |
| MBX Biosciences Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 10.84 per share. | 14 Feb 2025 | 49,070 | 3,255,000 | - | 10.8 | 531,919 | Common Stock |
| MBX Biosciences Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.85 per share. | 14 Feb 2025 | 29,540 | 3,205,930 | - | 9.9 | 290,969 | Common Stock |
| MBX Biosciences Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.90 per share. | 14 Feb 2025 | 17,962 | 3,176,390 | - | 9.9 | 177,824 | Common Stock |
| Compass Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 11 Feb 2025 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | ||
| MBX Biosciences Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 16 Sep 2024 | 19,587,284 | 0 | - | - | Series B Convertible Preferred Stock | ||
| MBX Biosciences Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 16 Sep 2024 | 12,372,634 | 0 | - | - | Series A Convertible Preferred Stock | ||
| MBX Biosciences Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 16 Sep 2024 | 4,854,368 | 0 | - | - | Series C Convertible Preferred Stock | ||
| MBX Biosciences Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 16 Sep 2024 | 2,658,428 | 2,658,428 | - | - | Common Stock | ||
| MBX Biosciences Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 16 Sep 2024 | 500,000 | 3,158,428 | - | 16 | 8,000,000 | Common Stock |
| MBX Biosciences Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 16 Sep 2024 | 403,787 | 403,787 | - | - | Common Stock | ||
| MBX Biosciences Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 16 Sep 2024 | 250,000 | 653,787 | - | 16 | 4,000,000 | Common Stock |
| MBX Biosciences Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 12 Sep 2024 | 15,963 | 15,963 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 21 Aug 2024 | 30,000 | 0 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 21 Aug 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 21 Aug 2024 | 26,400 | 26,400 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 21 Aug 2024 | 26,400 | 0 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 21 Aug 2024 | 18,500 | 0 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 21 Aug 2024 | 18,500 | 18,500 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 21 Aug 2024 | 18,500 | 18,500 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 21 Aug 2024 | 18,500 | 0 | - | - | Stock Option (Right to Buy) | ||
| Keros Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director | Sale of securities on an exchange or to another person at price $ 44.01 per share. | 13 Aug 2024 | 220,600 | 899,212 | - | 44.0 | 9,708,606 | Common Stock |
| Keros Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director | Sale of securities on an exchange or to another person at price $ 44.01 per share. | 13 Aug 2024 | 29,400 | 119,522 | - | 44.0 | 1,293,894 | Common Stock |
| Terns Pharma Inc | Carl L. Gordon | Director, Ten Percent Owner | 15 Jul 2024 | 39,433 | 4,843,421 | - | 10 | 394,330 | Common Stock | |
| Terns Pharma Inc | Carl L. Gordon | Director, Ten Percent Owner | 15 Jul 2024 | 6,142 | 756,258 | - | 10 | 61,420 | Common Stock | |
| Terns Pharma Inc | Carl L. Gordon | Director, Ten Percent Owner | 15 Jul 2024 | 5,401 | 1,968,480 | - | 10 | 54,010 | Common Stock | |
| Terns Pharma Inc | Carl L. Gordon | Director, Ten Percent Owner | 15 Jul 2024 | 4,009 | 4,839,412 | - | 10 | 40,090 | Common Stock | |
| Terns Pharma Inc | Carl L. Gordon | Director, Ten Percent Owner | 15 Jul 2024 | 623 | 755,635 | - | 10 | 6,230 | Common Stock | |
| Terns Pharma Inc | Carl L. Gordon | Director, Ten Percent Owner | 15 Jul 2024 | 556 | 1,967,924 | - | 10 | 5,560 | Common Stock | |
| Terns Pharma Inc | Carl L. Gordon | Director, Ten Percent Owner | 01 Jul 2024 | 4,676 | 4,676 | - | - | Stock Option (Right to Buy) | ||
| Terns Pharma Inc | Carl L. Gordon | Director, Ten Percent Owner | 10 Jun 2024 | 32,000 | 32,000 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 05 Jun 2024 | 26,400 | 26,400 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 5,900 | 11,800 | - | 0 | Common Stock | |
| Keros Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director | 30 May 2024 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | ||
| Compass Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 09 Feb 2024 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | ||
| ArriVent BioPharma Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 30 Jan 2024 | 821,827 | 821,827 | - | - | Common Stock | ||
| ArriVent BioPharma Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 30 Jan 2024 | 821,827 | 821,827 | - | - | Common Stock | ||
| ArriVent BioPharma Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 30 Jan 2024 | 821,827 | 0 | - | - | Series A Preferred Stock | ||
| ArriVent BioPharma Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 30 Jan 2024 | 821,827 | 0 | - | - | Series A Preferred Stock | ||
| ArriVent BioPharma Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 30 Jan 2024 | 469,615 | 1,291,442 | - | - | Common Stock | ||
| ArriVent BioPharma Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 30 Jan 2024 | 469,615 | 1,291,442 | - | - | Common Stock | ||
| ArriVent BioPharma Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 30 Jan 2024 | 469,615 | 0 | - | - | Series B Preferred Stock | ||
| ArriVent BioPharma Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 30 Jan 2024 | 469,615 | 0 | - | - | Series B Preferred Stock | ||
| ArriVent BioPharma Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 30 Jan 2024 | 222,222 | 1,513,664 | - | 18 | 3,999,996 | Common Stock |
| ArriVent BioPharma Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 30 Jan 2024 | 222,222 | 1,513,664 | - | 18 | 3,999,996 | Common Stock |
| Adicet Bio Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.40 per share. | 25 Jan 2024 | 1,841,100 | 7,526,359 | - | 2.4 | 4,418,640 | Common Stock |
| Adicet Bio Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.40 per share. | 25 Jan 2024 | 1,041,700 | 1,255,985 | - | 2.4 | 2,500,080 | Common Stock |
| Adicet Bio Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.40 per share. | 25 Jan 2024 | 242,200 | 990,254 | - | 2.4 | 581,280 | Common Stock |
| Adicet Bio Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 14 Aug 2023 | 30,000 | 0 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 14 Aug 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 14 Aug 2023 | 26,400 | 26,400 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 14 Aug 2023 | 26,400 | 0 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 14 Aug 2023 | 18,500 | 18,500 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 14 Aug 2023 | 18,500 | 0 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 14 Aug 2023 | 18,500 | 18,500 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | 14 Aug 2023 | 18,500 | 0 | - | - | Stock Option (Right to Buy) | ||
| Theseus Pharmaceuticals Inc | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.05 per share. | 17 Jul 2023 | 328,482 | 17,063,000 | - | 3.0 | 1,001,870 | Common Stock |
| Theseus Pharmaceuticals Inc | Carl L. Gordon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.05 per share. | 17 Jul 2023 | 151,450 | 650,600 | - | 3.1 | 461,923 | Common Stock |
| Adicet Bio Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.09 per share. | 27 Jun 2023 | 442,000 | 5,685,259 | - | 2.1 | 923,780 | Common Stock |
| Adicet Bio Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.09 per share. | 27 Jun 2023 | 250,000 | 646,657 | - | 2.1 | 522,500 | Common Stock |
| Adicet Bio Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.09 per share. | 27 Jun 2023 | 125,000 | 1,027,885 | - | 2.1 | 261,250 | Common Stock |
| Adicet Bio Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.09 per share. | 27 Jun 2023 | 58,000 | 748,054 | - | 2.1 | 121,220 | Common Stock |
| Theseus Pharmaceuticals Inc | Carl L. Gordon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 19,500 | 19,500 | - | - | Stock Option (right to buy) | |
| Theseus Pharmaceuticals Inc | Carl L. Gordon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 3,250 | 3,250 | - | - | Restricted Stock Unit | |
| Kinnate Biopharma Inc | Carl L. Gordon | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Keros Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director | 06 Jun 2023 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | ||
| Adicet Bio Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director | 01 Jun 2023 | 26,400 | 26,400 | - | - | Stock Option (Right to Buy) | ||
| Adicet Bio Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 5,900 | 5,900 | - | 0 | Common Stock |